There could be new hope for some people diagnosed with pancreatic cancer.
Researches announced yesterday that patients with pancreatic cancer that hadn’t spread lived substantially longer on a new four-drug combination than on a single standard cancer drug.
Experts say it could be a big step forward for the small group of patients whose pancreatic cancer is diagnosed early enough to be removed by surgery.
